The post VanEck and Jito file the first liquid staking-backed Solana ETF appeared on BitcoinEthereumNews.com. Jito announced the filing of an exchange-traded fund (ETF) based entirely on Solana liquid staking tokens in a partnership with VanEck. According to an Aug. 22 announcement, the filing represents months of collaborative regulatory outreach between Jito and VanEck, beginning with initial meetings with the US Securities and Exchange Commission (SEC) in February.  The partnership aims to combine Solana exposure with staking rewards in a regulated wrapper accessible to traditional investors. Matthew Sigel, head of digital assets research at VanEck, described the filing as selective but significant.  He stated via X: “We’ve been very selective with our single-token ETF filings this year, but today’s S-1 for the VanEck JitoSOL ETF matters. If listed, it would represent a new piece of market infrastructure that bridges DeFi innovation with TradFi accessibility.” Regulatory clarity The filing builds on SEC staff guidance issued on Aug. 5, which clarified that liquid staking activities do not constitute securities transactions when properly structured.  This guidance essentially removed the final regulatory hurdle for staking-enabled crypto ETFs. Jito’s preparation included a March 2025 securities classification report explaining why JitoSOL operates as a decentralized infrastructure rather than a security.  The company participated in regulatory comment periods during the summer of 2025, providing feedback on the safe use of liquid staking tokens in exchange-traded products. Operational benefits The announcement noted that the JitoSOL structure offers key advantages for institutional investors. Liquid staking tokens eliminate unbonding delays, allowing daily ETF creation and redemption while maintaining staking reward accrual.  The approach provides regulatory clarity through standard ETF accounting methods, giving investors access to staked Solana yields without operational complications. Staking yields can offset or exceed expense ratios on networks like Solana, potentially improving long-term returns. The structure supports network security by decentralizing stake across validators, meaning investors contribute to blockchain health. Jito Foundation Chief… The post VanEck and Jito file the first liquid staking-backed Solana ETF appeared on BitcoinEthereumNews.com. Jito announced the filing of an exchange-traded fund (ETF) based entirely on Solana liquid staking tokens in a partnership with VanEck. According to an Aug. 22 announcement, the filing represents months of collaborative regulatory outreach between Jito and VanEck, beginning with initial meetings with the US Securities and Exchange Commission (SEC) in February.  The partnership aims to combine Solana exposure with staking rewards in a regulated wrapper accessible to traditional investors. Matthew Sigel, head of digital assets research at VanEck, described the filing as selective but significant.  He stated via X: “We’ve been very selective with our single-token ETF filings this year, but today’s S-1 for the VanEck JitoSOL ETF matters. If listed, it would represent a new piece of market infrastructure that bridges DeFi innovation with TradFi accessibility.” Regulatory clarity The filing builds on SEC staff guidance issued on Aug. 5, which clarified that liquid staking activities do not constitute securities transactions when properly structured.  This guidance essentially removed the final regulatory hurdle for staking-enabled crypto ETFs. Jito’s preparation included a March 2025 securities classification report explaining why JitoSOL operates as a decentralized infrastructure rather than a security.  The company participated in regulatory comment periods during the summer of 2025, providing feedback on the safe use of liquid staking tokens in exchange-traded products. Operational benefits The announcement noted that the JitoSOL structure offers key advantages for institutional investors. Liquid staking tokens eliminate unbonding delays, allowing daily ETF creation and redemption while maintaining staking reward accrual.  The approach provides regulatory clarity through standard ETF accounting methods, giving investors access to staked Solana yields without operational complications. Staking yields can offset or exceed expense ratios on networks like Solana, potentially improving long-term returns. The structure supports network security by decentralizing stake across validators, meaning investors contribute to blockchain health. Jito Foundation Chief…

VanEck and Jito file the first liquid staking-backed Solana ETF

2 min read

Jito announced the filing of an exchange-traded fund (ETF) based entirely on Solana liquid staking tokens in a partnership with VanEck.

According to an Aug. 22 announcement, the filing represents months of collaborative regulatory outreach between Jito and VanEck, beginning with initial meetings with the US Securities and Exchange Commission (SEC) in February. 

The partnership aims to combine Solana exposure with staking rewards in a regulated wrapper accessible to traditional investors.

Matthew Sigel, head of digital assets research at VanEck, described the filing as selective but significant. 

He stated via X:

Regulatory clarity

The filing builds on SEC staff guidance issued on Aug. 5, which clarified that liquid staking activities do not constitute securities transactions when properly structured. 

This guidance essentially removed the final regulatory hurdle for staking-enabled crypto ETFs.

Jito’s preparation included a March 2025 securities classification report explaining why JitoSOL operates as a decentralized infrastructure rather than a security. 

The company participated in regulatory comment periods during the summer of 2025, providing feedback on the safe use of liquid staking tokens in exchange-traded products.

Operational benefits

The announcement noted that the JitoSOL structure offers key advantages for institutional investors. Liquid staking tokens eliminate unbonding delays, allowing daily ETF creation and redemption while maintaining staking reward accrual. 

The approach provides regulatory clarity through standard ETF accounting methods, giving investors access to staked Solana yields without operational complications.

Staking yields can offset or exceed expense ratios on networks like Solana, potentially improving long-term returns. The structure supports network security by decentralizing stake across validators, meaning investors contribute to blockchain health.

Jito Foundation Chief Commercial Officer Thomas Uhm worked with ETF issuers, custodians, and exchanges to establish infrastructure enabling VanEck’s product launch. The effort received support from Multicoin Capital, the Solana Foundation, and VanEck.

Further, VanEck and Jito join Canary Capital and Marinade in the group of issuers partnering with liquid staking protocols. Canary amended its Solana ETF filing in May 2025 to name Marinade Select as its staking provider.

The S-1 filing initiates a review process before potential market listing, positioning Jito to advance institutional crypto adoption through regulated on-chain finance products.

Mentioned in this article

Source: https://cryptoslate.com/vaneck-and-jito-file-the-first-liquid-staking-backed-solana-etf/

Market Opportunity
DeFi Logo
DeFi Price(DEFI)
$0.00034
$0.00034$0.00034
-3.68%
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29